Dr Michael Chaump, MD | |
1 Malcolm Ave, Teterboro, NJ 07608 | |
(201) 393-5000 | |
Not Available |
Full Name | Dr Michael Chaump |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1 Malcolm Ave, Teterboro, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598963894 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25MA09670200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael Chaump, MD 1 Malcolm Ave, Teterboro, NJ 07608-1070 Ph: (201) 393-5000 | Dr Michael Chaump, MD 1 Malcolm Ave, Teterboro, NJ 07608 Ph: (201) 393-5000 |
News Archive
So-called barrier sites - the skin, gut, lung - limit the inner body's exposure to allergens, pollutants, viruses, bacteria, and parasites. Understanding how the immune system works in these external surfaces has implications for understanding such inflammatory diseases as asthma, psoriasis, IBD, and food allergies, all of which occur at the body's barriers.
Researchers from the Spanish National Cancer Research Centre have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis. The discovery, published in Cancer Cell, will help to identify unique aspects of melanoma that could contribute to determine the risk of developing metastasis in patients with this disease.
Especially in settings where personal protective equipment, or PPE, is in short supply, intubation - inserting a breathing tube down a patient's throat - poses a major risk of SARS-CoV-2 exposure for doctors and nurses as viral particles are released into the air.
New 12-month data from the Smidt Heart Institute at Cedars-Sinai backs up an earlier study proving that a pharmacist-led, barbershop-based medical intervention can successfully lower blood pressure in high-risk African-American men. The follow-up research was published today in the journal Circulation.
As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.
› Verified 1 days ago
Marina Gerber, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-5357 Fax: 201-462-4712 | |
Leza N Gallo, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, 1 Malcolm Avenue, Teterboro, NJ 07608 Phone: 201-393-5035 | |
Dr. Uma Ayer, M.D Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07606 Phone: 203-393-5606 | |
William Ellsworth Tarr Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Quest Diagnostics Inc, Teterboro, NJ 07608 Phone: 201-393-5752 | |
Xinzhu Pang, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, One Malcolm Ave, Teterboro, NJ 07068 Phone: 201-893-5632 | |
Dr. Ronald David Luff, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6007 Fax: 201-462-4772 | |
Ecaterina F Tamas, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6317 |